Andrea Riccardo Filippi

15PUBLICATIONS
55CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersNutrigenomics and personalised nutritionMedical infection agents (incl. prions)Radiation therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Aug 27, 2026
Radiation-Free Therapy for the Initial Treatment of Good Prognosis Early Non-Bulky Hodgkin Lymphoma, Defined by a Low Metabolic Tumor Volume and a Negative Interim PET After 2 Chemotherapy Cycles: The RAFTING Trial Protocol.

|May 14, 2025
Chemotherapy-Free Treatment with Radiotherapy and Immunotherapy for Locally Advanced Non-Small Cell Lung Cancer.

M Zeeshan Ozair, Balazs Halmos, Angelica D'Aiello

|Jun 28, 2023
The Role of Native T1 and T2 Mapping Times in Identifying PD-L1 Expression and the Histological Subtype of NSCLCs.

Chandra Bortolotto, Gaia Messana, Antonio Lo Tito

|Nov 26, 2022
Correlation between PD-L1 Expression of Non-Small Cell Lung Cancer and Data from IVIM-DWI Acquired during Magnetic Resonance of the Thorax: Preliminary Results.

Chandra Bortolotto, Giulia Maria Stella, Gaia Messana

|Nov 15, 2021
DUART: durvalumab after radiotherapy in patients with unresectable, stage III NSCLC who are ineligible for chemotherapy.

Andrea R Filippi, Rafał Dziadziuszko, Maria Rosario García Campelo

|Oct 01, 2021
Role of radiotherapy to bulky sites of advanced Hodgkin lymphoma treated with ABVD: final results of FIL HD0801 trial.

Umberto Ricardi, Mario Levis, Andrea Evangelista

Pageof 3

Frequent Collaborators

5 joint publications

Giulia Maria Stella

3 joint publications

Chandra Bortolotto

2 joint publications

Alessia Gerbasi

2 joint publications

Gaia Messana